Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

A tug-of-war between severe acute respiratory syndrome coronavirus 2 and host antiviral defence: lessons from other pathogenic viruses
Sin‐Yee Fung, Kit‐San Yuen, Zi‐Wei Ye, et al.
Emerging Microbes & Infections (2020) Vol. 9, Iss. 1, pp. 558-570
Open Access | Times Cited: 388

Showing 26-50 of 388 citing articles:

Coronavirus disease-2019: A tocsin to our aging, unfit, corpulent, and immunodeficient society
David C. Nieman
Journal of sport and health science/Journal of Sport and Health Science (2020) Vol. 9, Iss. 4, pp. 293-301
Open Access | Times Cited: 126
Lung under attack by COVID-19-induced cytokine storm: pathogenic mechanisms and therapeutic implications
Corrado Pelaia, Caterina Tinello, Alessandro Vatrella, et al.
Therapeutic Advances in Respiratory Disease (2020) Vol. 14
Open Access | Times Cited: 126
Invited Review: The spectrum of neuropathology in COVID‐19
Safa Al‐Sarraj, Claire Troakes, Brian Hanley, et al.
Neuropathology and Applied Neurobiology (2020) Vol. 47, Iss. 1, pp. 3-16
Open Access | Times Cited: 124
Pandemia da COVID-19: o maior desafio do século XXI
Sávio Breno Pires Brito, Isaque Oliveira Braga, Carolina Cunha, et al.
Vigilância Sanitária em Debate (2020) Vol. 8, Iss. 2, pp. 54-63
Open Access | Times Cited: 123
Viral Emerging Diseases: Challenges in Developing Vaccination Strategies
Maria Trovato, Rossella Sartorius, Luciana D’Apice, et al.
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 119
The role of cysteine peptidases in coronavirus cell entry and replication: The therapeutic potential of cathepsin inhibitors
Anja Pišlar, Ana Mitrović, Jerica Sabotič, et al.
PLoS Pathogens (2020) Vol. 16, Iss. 11, pp. e1009013-e1009013
Open Access | Times Cited: 105
Harnessing innate immunity to eliminate SARS-CoV-2 and ameliorate COVID-19 disease
Rachel M. Golonka, Piu Saha, Beng San Yeoh, et al.
Physiological Genomics (2020) Vol. 52, Iss. 5, pp. 217-221
Open Access | Times Cited: 103
Obesity, the most common comorbidity in SARS-CoV-2: is leptin the link?
Candida J. Rebello, John P. Kirwan, Frank L. Greenway
International Journal of Obesity (2020) Vol. 44, Iss. 9, pp. 1810-1817
Open Access | Times Cited: 101
Immune Response and COVID-19: A mirror image of Sepsis
Eduardo López‐Collazo, José Avendaño‐Ortiz, Alejandro Martín‐Quirós, et al.
International Journal of Biological Sciences (2020) Vol. 16, Iss. 14, pp. 2479-2489
Open Access | Times Cited: 99
The coronavirus disease 2019 vaccine in pregnancy: risks, benefits, and recommendations
Irene Stafford, Jacqueline G. Parchem, Baha M. Sibai
American Journal of Obstetrics and Gynecology (2021) Vol. 224, Iss. 5, pp. 484-495
Open Access | Times Cited: 98
Viral G-quadruplexes: New frontiers in virus pathogenesis and antiviral therapy
Emanuela Ruggiero, Sara N. Richter
Annual reports in medicinal chemistry (2020), pp. 101-131
Open Access | Times Cited: 94
Immune dysregulation and system pathology in COVID-19
Muhammad Jamal, Hina Iqbal Bangash, Maria Habiba, et al.
Virulence (2021) Vol. 12, Iss. 1, pp. 918-936
Open Access | Times Cited: 93
The current understanding and potential therapeutic options to combat COVID-19
Venkatesh Pooladanda, Sowjanya Thatikonda, Chandraiah Godugu
Life Sciences (2020) Vol. 254, pp. 117765-117765
Open Access | Times Cited: 89
Understanding the age divide in COVID-19: why are children overwhelmingly spared?
Krithika Lingappan, Harry Karmouty‐Quintana, Jonathan Davies, et al.
AJP Lung Cellular and Molecular Physiology (2020) Vol. 319, Iss. 1, pp. L39-L44
Open Access | Times Cited: 89
Dynamically evolving novel overlapping gene as a factor in the SARS-CoV-2 pandemic
Chase W. Nelson, Zachary Ardern, Tony L. Goldberg, et al.
eLife (2020) Vol. 9
Open Access | Times Cited: 88
Immunology, immunopathogenesis and immunotherapeutics of COVID-19; an overview
Leila Mohamed Khosroshahi, Mohsen Rokni, Tahmineh Mokhtari, et al.
International Immunopharmacology (2021) Vol. 93, pp. 107364-107364
Open Access | Times Cited: 88
Lung transcriptome of a COVID-19 patient and systems biology predictions suggest impaired surfactant production which may be druggable by surfactant therapy
Abul Bashar Mir Md. Khademul Islam, Md. Abdullah‐Al‐Kamran Khan
Scientific Reports (2020) Vol. 10, Iss. 1
Open Access | Times Cited: 86
Network Analysis and Transcriptome Profiling Identify Autophagic and Mitochondrial Dysfunctions in SARS-CoV-2 Infection
Komudi Singh, Yunching Chen, Shahin Hassanzadeh, et al.
Frontiers in Genetics (2021) Vol. 12
Open Access | Times Cited: 85
The roles of signaling pathways in SARS-CoV-2 infection; lessons learned from SARS-CoV and MERS-CoV
Nima Hemmat, Zahra Asadzadeh, Noora Karim Ahangar, et al.
Archives of Virology (2021) Vol. 166, Iss. 3, pp. 675-696
Open Access | Times Cited: 80
Could hemophagocytic lymphohistiocytosis be the core issue of severe COVID-19 cases?
Violetta Opoka‐Winiarska, Ewelina Grywalska, Jacek Roliński
BMC Medicine (2020) Vol. 18, Iss. 1
Open Access | Times Cited: 79
NSAIDs in patients with viral infections, including Covid-19: Victims or perpetrators?
Annalisa Capuano, Cristina Scavone, Giorgio Racagni, et al.
Pharmacological Research (2020) Vol. 157, pp. 104849-104849
Open Access | Times Cited: 78
miRNAs; a novel strategy for the treatment of COVID‐19
Ying Hao, Mohsen Ebrahimi, Mona Keivan, et al.
Cell Biology International (2021) Vol. 45, Iss. 10, pp. 2045-2053
Open Access | Times Cited: 78
Apoptosis‐induced T‐cell lymphopenia is related to COVID‐19 severity
Ahmet Çizmecioğlu, Hilal Akay Çizmecioğlu, Mevlüt Hakan Göktepe, et al.
Journal of Medical Virology (2020) Vol. 93, Iss. 5, pp. 2867-2874
Closed Access | Times Cited: 77
Less Can Be More: The Hormesis Theory of Stress Adaptation in the Global Biosphere and Its Implications
Volker Schirrmacher
Biomedicines (2021) Vol. 9, Iss. 3, pp. 293-293
Open Access | Times Cited: 77
Upregulated type I interferon responses in asymptomatic COVID-19 infection are associated with improved clinical outcome
Kiran Iqbal Masood, Maliha Yameen, Javeria Ashraf, et al.
Scientific Reports (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 75

Scroll to top